Trials / Completed
CompletedNCT05969067
Retroperitoneal Tunneling Versus Dissection Technique During Sacrocolpopexy
Comparing Retroperitoneal Tunneling Versus Dissection Technique During Robotic Assisted Sacrocolpopexy for Pelvic Organ Prolapse
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- The University of Texas Medical Branch, Galveston · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare operative time, patient reported outcomes, surgical complications, and surgical outcomes between the tunneling versus dissection technique during robotic assisted sacrocolpopexy (RA SCP).
Detailed description
Women with symptomatic, stage II to IV POP who plan RA SCP at UTMB Health will be approached to participate. Using the study protocol inclusion and exclusion criteria, patient's eligibility will be determined. All eligible subjects will provide the written informed consent before any research data is collected. All screening assessments will be completed at a preoperative, in-person, clinic visit, and within 60 days of surgery. The subject will then undergo randomization to tunneling versus dissection technique during RA SCP with the total sample size of 40 female subjects (20 per group). Concomitant procedures for POP or urinary incontinence are permitted and will be based upon the operating surgeons' standard clinical practice and best clinical judgement. Subsequently, the subject will have postoperative follow up at 2 weeks, 6 weeks and 3 months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Tunneling Technique during RA SCP | As described in the intervention arm above |
| PROCEDURE | Dissection Technique during RA SCP | As described in the intervention arm above |
Timeline
- Start date
- 2023-08-10
- Primary completion
- 2024-08-01
- Completion
- 2024-09-01
- First posted
- 2023-08-01
- Last updated
- 2025-04-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05969067. Inclusion in this directory is not an endorsement.